NUP214 and Hypertension: Controlled brain-specific inhibition of CaN has yet to be discovered, and as of right now, generalized inhibition of this protein could lead to immunosuppression, hypertension, metabolic abnormalities, malignancies, and other side effects that are difficult to control for [31].